| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 200825-1G |
|
1616688-62-0 |
[S(R)]-N-[(S)-[2-(二苯基膦)苯基](4-甲氧基苯基)甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C30H32NO2PS | |
| 200825-100MG |
|
1616688-62-0 |
[S(R)]-N-[(S)-[2-(二苯基膦)苯基](4-甲氧基苯基)甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥95%,- |
100MG | 需詢價(jià) | C30H32NO2PS | |
| 200824-1G |
|
1616688-59-5 |
[S(R)]-N-[(R)-[2-(二苯基膦)苯基]苯基甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C29H30NOPS | |
| 200824-100MG |
|
1616688-59-5 |
[S(R)]-N-[(R)-[2-(二苯基膦)苯基]苯基甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥95%,- |
100MG | 需詢價(jià) | C29H30NOPS | |
| 200823-1G |
|
1595319-97-3 |
[S(R)]-N-[(S)-[2-(二苯基膦)苯基]苯基甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C29H30NOPS | |
| 200823-100MG |
|
1595319-97-3 |
[S(R)]-N-[(S)-[2-(二苯基膦)苯基]苯基甲基]-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥95%,- |
100MG | 需詢價(jià) | C29H30NOPS | |
| 200707-100MG |
|
NA |
(S)-螺環(huán)二溴 (S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-dibromo 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C17H14Br2 | |
| 200706-100MG |
|
NA |
(R)-螺環(huán)二溴 (R)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-dibromo 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C17H14Br2 | |
| 200471-100MG |
|
188780-28-1 |
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H24N2O2 | |
| 200470-100MG |
|
NA |
(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H24N2O2 | |
| 200469-100MG |
|
NA |
(4S,4'S,5R,5'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-??4,5-二苯基惡唑] (4S,4'S,5R,5'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C39H32N2O2 | |
| 200468-100MG |
|
1656253-81-4 |
(4R,4'R,5S,5'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4,5-二苯基惡唑] (4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C39H32N2O2 | |
| 200467-100MG |
|
NA |
(4S,4'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-叔丁基惡唑] (4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H32N2O2 | |
| 200466-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-叔丁基惡唑] (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H32N2O2 | |
| 200465-100MG |
|
NA |
(4S,4'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-異丙基惡唑] (4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C21H28N2O2 | |
| 200464-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-異丙基惡唑] (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C21H28N2O2 | |
| 200463-100MG |
|
188780-32-7 |
(4S,4'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-苯基惡唑] (4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-phenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H24N2O2 | |
| 200462-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-苯基惡唑] (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-phenyloxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H24N2O2 | |
| 200461-100MG |
|
1003886-09-6 |
(4S,4'S)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-芐基惡唑] (4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H28N2O2 | |
| 200460-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-二氫-2H-茚-2-甲基叉雙[?4,?5-?二氫-?4-芐基惡唑] (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole] 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H28N2O2 | |
小泰
|
010-60710855
|